Don't miss out on Monday 28th October 2024, when Inari Medical (NASDAQ: NARI) will disclose its third quarter financial results after market close. Investors will have the chance to learn more about the company's performance during the quarter.
Financial analysts on Wall Street are predicting that the concern is about to reveal an estimated $0.11 loss per share for the quarter. Additionally, the company is projected to announce a total revenue of $150.67 million for this period.
According to analysts on Wall Street, the company's full-year performance is projected to result in a total revenue of $600.18 million. Additionally, they forecast the earnings per share to hit loss of $0.77 for the fiscal year.
In the corresponding quarter of the previous year, the company's earnings report unveiled a per-share income of $0.05. Notably, the company's total revenue reached an impressive $126.37 million during that specific period.
Additionally, The company will host a conference call with investors and analysts on 28th October 2024 at 04:30 PM eastern time to review the Q3 2024 financial results.
During Thursday's trading, Inari Medical (NARI) shares reached a low of $43.68 and a high of $44.94, along with a total volume of 492.00 thousand shares. The stock ended the regular trading session at $43.96, showing decline of 0.34 percent.
